SARS-CoV-2 Variant Inhibitor Screening Kit
R&D Systems, Inc. a Bio-Techne Brand
Now with Omicron and Delta Variant!
Key Product Details
|Assay Type:||ELISA Type Binding Assay|
|Sample Types:||Cell Lysates|
|SARS-CoV-2 Variant Inhibitor Screening Kit Features:||
Background: Severe acute respiratory syndrome Coronavirus-2
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19, has posed a serious threat to global human health. With the emergence of variants, especially the Variants of Concern (VOCs), a quick and effective way to assess how effective the current vaccines are against the major variants is needed. The COVID-19 Neutralization Kit is an ELISA type of binding assay measuring the ability of the sera of vaccinated donors to block the binding between RBDs of COVID-19 variants and human ACE-2.
See the Data: Read our white paper on testing individual serum samples using this kit. Download White Paper
Assay Workflow: 5 Simple Steps
Customers also Viewed
Citations for SARS-CoV-2 Variant Inhibitor Screening Kit
Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.